Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases presents recent advances in the vivid molecular pathways targeting angiogenesis, inflammation, and oxidative stress that contribute very widely to the genesis of chronic diseases. The books highlights drugs from natural and synthetic origins in the management/prevention/treatment of diseases, along with the drug delivery approaches. The book's authors from various key institutions around the globe deliver well-structured and designed chapters. The systematic presented information and knowledge will surely aid consistency and continuity. The multifaceted book is enriched with deep scientific content. Each chapter clearly defines the facts, the emerging role of molecular pathways, and targets and focus, along with key challenges and future directions that will provide new areas for researchers to explore new targets in the domain.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Understanding the role of angiogenesis, inflammation and oxidative stress in diabetes mellitus: insights into the past, present and future trends2. Targeting angiogenesis, inflammation, and oxidative stress in obesity
3. Molecular role of angiogenesis, inflammation and oxidative stress in cancer
4. Rheumatoid arthritis: Its etiology, pathophysiology, and treatment
5. Inflammatory bowel diseases (IBDs)
6. Natural and synthetic agents targeting angiogenesis, oxidative stress, and inflammation in psoriasis
7. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives
8. Decrypting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure
9. Expatiating the role of angiogenesis, inflammation and oxidative stress in angina pectoris: A state-of-the-art on the drug delivery approaches
10. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's siseases
11. Advancement in herbal drugs for the treatment of Parkinson's disease
12. Targeting angiogenesis, inflammation, and oxidative stress in depression
13. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy
14. Diabetic retinopathy: Stressing the function of angiogenesis, inflammation and oxidative stress in the disease
15. Targeting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of glaucoma: Strategic nanotechnology based drug delivery approaches
16. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches
17. Intricate the potential role of nanotechnology as cutting-edge for management of hirsutism and gynecosmatia: A paradigm in therapeutics
18. Role of angiogenesis, inflammation and oxidative stress in polycystic ovary syndrome (PCOS): Current perspectives
Authors
Tapan Behl Professor, Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India.Professor Tapan Behl is based at Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India. Dr. Tapan Behl completed his doctoral studies from Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India and thereafter worked as Post-Doctoral Researcher. His areas of interest include diabetes and associated complications, molecular pharmacology and neuropathic pain and its complications. Dr. Behl has published more than 400 research and review papers in International and National journals. He has also published International books and is continuously engaged in exploring the molecular mechanisms in diabetes and related complications, rheumatoid arthritis and obesity.
Sukhbir Singh Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India.Professor Sukhbir Singh has a PhD in Pharmaceutical Science and experience of more than 15 years in academia and research. He has 170 publications in various National/International journal of repute, 8 books, 12 books chapter and filed 19 patents to his credit. He has presented/published 40 review/research abstracts in various National/International conferences. His areas of interest in research are nanotechnology/liposome/niosomes/SEDDS based formulation development and solubility enhancement of BCS class II drugs. He has expertise in operation of various statistical analysis tools
Neelam Sharma Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India. Dr. Neelam Sharma, PhD in Pharmaceutical Science has experience of more than 13 years in academics and research. She is highly self-determined and organized pharmaceutical research professional. She has 140 publications in various National/International journal of repute, h-index 12 and i 10-index 20, 08 books, 12 books chapter and filed 19 patents to his credit. She has presented/published 35 review/research abstracts in various National/International conferences. She has completed 4 consultancy projects on herbal/homeopathic formulation. She and her team received IEDC, Govt of India, prototyping grant of Rs 2.5 lacs for project related to management of ARDS in COVID, held at Chitkara University, Punjab in 2020 and project has been completed in 2022. She has guided 1 PhD students and 20 M. Pharmacy students and 6 Ph.D students are pursuing PhD under her guidance.
